| |
Patients studied n
|
n
|
(%)
|
---|
Sex: male
| |
651
|
404
|
(62.1)
|
Age (years)
|
M (range)
|
651
|
77 (65-100)
| |
High MFI
| |
651
|
115
|
(17.7)
|
Social class
| |
511
| | |
|
I
| |
14
|
(2.7)
|
|
II
| |
7
|
(1.4)
|
|
III
| |
47
|
(9.2)
|
|
IVa
| |
183
|
(35.8)
|
|
IVb
| |
74
|
(14.5)
|
|
V
| |
186
|
(36.4)
|
Educational level
|
≥secondary level
|
643
|
101
|
(15.7)
|
Living alone
| |
651
|
77
|
(11.8)
|
Alcohol consumption
| |
561
|
51
|
(9.1)
|
Smoker or ex-smoker
| |
648
|
342
|
(52.8)
|
Admitting hospital
| |
651
| | |
|
1
| |
117
|
(18.0)
|
|
2
| |
163
|
(25.0)
|
|
3
| |
233
|
(35.8)
|
|
4
| |
48
|
(7.4)
|
|
5
| |
90
|
(13.8)
|
Underlying diseases
| |
651
|
460
|
(70.7)
|
COPD
| | |
221
|
(33.9)
|
Diabetes mellitus
| | |
130
|
(20.0)
|
Solid or haematologic neoplasia
| | |
96
|
(14.8)
|
Disabling neurological disease
| | |
86
|
(13.2)
|
Heart failure
| | |
64
|
(9.8)
|
Aggressive therapy
a
| | |
48
|
(7.4)
|
Liver disease
| | |
21
|
(3.2)
|
Other diseases
b
| | |
29
|
(4.4)
|
Pneumonia Severity Index
| |
589
| | |
|
Risk class 1
| |
2
|
(0.3)
|
|
Risk class 2
| |
39
|
(6.6)
|
|
Risk class 3
| |
173
|
(29.4)
|
|
Risk class 4
| |
286
|
(48.6)
|
|
Risk class 5
| |
89
|
(15.1)
|
Combined antibiotic treatment
| |
651
|
251
|
(38.6)
|
Bacteremic pneumonia
| |
405
|
55
|
(13.6)
|
Empyema
| |
651
|
17
|
(2.6)
|
Pneumonia outcomes
| | | | |
LOS (days):
|
M (range)
|
651
|
8 (1-95)
| |
Mortality in the first 30 days
| |
651
|
41
|
(6.3)
|
Readmission c
| |
604
|
64
|
(10.6)
|
ICU admission
| |
651
|
51
|
(7.8)
|
- Data are presented as n (%) or median (range).
- Abbreviations: COPD: Chronic obstructive pulmonary disease; ICU: Intensive Care Unit; LOS: length of stay; M: Median; MFI: Municipality Family Income.
- Notes: a Aggressive therapy: radiotherapy or corticosteroids therapy or immunosuppressive therapy.
-
b Other diseases: Autoimmune disease or chronic renal failure in dialysis.
-
c In order to evaluate readmission, deaths during hospitalization were excluded.